Search by :

 

 
Flu Testing Update 11-21-2016
News/Tech Bulletins

With the flu season in full swing, Clinical Labs of Hawaii would like to remind all providers of our current test options.

Test Update- Cancer Antigen 15-3 11-21-2016
News/Tech Bulletins

Effective November 14, 2016, the Cancer Antigen 15-3 assay is being performed on the Roche COBAS and as a result, the reference range has been updated.

Unfractionated Heparin Test Update 11-17-2016
News/Tech Bulletins

Unfractionated Heparin Testing is now available on Maui.

HMSA Precertification Request Update 10-27-2016
News/Tech Bulletins

Explanation of HMSA's precertification process

Medicare MolDx Excluded List Update 10-27-2016
News/Tech Bulletins

On September 1, 2016, Medicare published an updated version of its statutorily excluded Molecular Diagnostic (MolDx) tests. This bulletin provides an explanation and instructions on how to access this list.

Test Update: More Collection Sites for the H.pylori Breath Test 10-19-2016
News/Tech Bulletins

Expanded collection sites now available for the H.pylori Breath Test. 

New Test- Meningitis/Encephalitis Panel 10-17-2016
News/Tech Bulletins

The Film Array Meningitis/Encephalitis Panel is an FDA approved, comprehensive, multiplex molecular assay which accurately detects multiple organisms, including viruses, all on a single, minimal volume CSF specimen.

Respiratory Panel PCR Test Update 09-30-2016
News/Tech Bulletins

Beginning October 3, 2016, Kapiolani Medical Center for Women and Children will offer the Respiratory Panel by PCR on site to assist healthcare providers with faster diagnoses, improved antibiotic stewardship and quicker results. This test will continue to be offered at our reference lab as well.

Coagulation Testing Reference Range Update 09-26-2016
News/Tech Bulletins

Heparin Therapeutic Range will be adjusted effective September 26, 2016.

New Test: M.TB Direct PCR 09-19-2016
News/Tech Bulletins

The Cepheid Xpert® MTB/RIF Direct PCR assay rapidly identifies M. tuberculosis organisms, simultaneously detects rifampin-resistant MTB, and aids in the decision of whether continued airborne infection isolation is warranted for patients with suspected pulmonary tuberculosis.

Page 2 of 5
<<first | prev | 1 2 3 4 5 | next | last>>